McKesson Corporation (MCK)

NYSE: MCK · IEX Real-Time Price · USD
363.61
+5.48 (1.53%)
Feb 7, 2023, 4:03 PM EST - Market closed
1.53%
Market Cap 51.56B
Revenue (ttm) 273.90B
Net Income (ttm) 3.14B
Shares Out 141.79M
EPS (ttm) 21.78
PE Ratio 16.69
Forward PE 14.25
Dividend $2.02 (0.56%)
Ex-Dividend Date Nov 30, 2022
Volume 843,016
Open 357.70
Previous Close 358.13
Day's Range 355.73 - 364.54
52-Week Range 260.73 - 401.78
Beta 0.61
Analysts Buy
Price Target 430.88 (+18.5%)
Earnings Date Feb 1, 2023

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]

Sector Healthcare
Founded 1833
Employees 58,000
Stock Exchange NYSE
Ticker Symbol MCK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $430.88, which is an increase of 18.50% from the latest price.

Price Target
$430.88
(18.50% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Here's Why McKesson (MCK) is Poised for a Turnaround After Losing -6.24% in 4 Weeks

The heavy selling pressure might have exhausted for McKesson (MCK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in...

14 hours ago - Zacks Investment Research

Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"

McKesson (MCK) could produce exceptional returns because of its solid growth attributes.

4 days ago - Zacks Investment Research

5 Dental Supplies Stocks to Buy Amid Recovering Prospects

Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.

Other symbols: ABCCAHLHMMSI
4 days ago - Zacks Investment Research

McKesson (MCK) Q3 Earnings Surpass Estimates, EPS View Up

McKesson's (MCK) third-quarter fiscal 2023 results benefit from segmental growth.

5 days ago - Zacks Investment Research

McKesson (MCK) Tops Q3 Earnings and Revenue Estimates

McKesson (MCK) delivered earnings and revenue surprises of 8.83% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

6 days ago - Zacks Investment Research

McKesson Corporation Reports Fiscal 2023 Third-Quarter Results

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2023 third-quarter financial results. Results can be accessed on McKesson's Investor Relations website at inv...

6 days ago - Business Wire

Are Medical Stocks Lagging McKesson (MCK) This Year?

Here is how McKesson (MCK) and Annovis Bio, Inc. (ANVS) have performed compared to their sector so far this year.

6 days ago - Zacks Investment Research

7 Healthcare Stocks That Will Be Big Winners in 2023

Healthcare stocks performed well in 2022, driven by a number of factors. One of the main drivers was the ongoing COVID-19 pandemic, which continued to boost demand for healthcare products and services...

Other symbols: HRMYLLYMRKNVOUNHVIR
1 week ago - InvestorPlace

2 Medical Stocks to Consider Buying Before Earnings

There is a continued need for prosperous healthcare companies, here are two medical stocks investors may want to consider buying ahead of earnings this week.

Other symbols: SNY
1 week ago - Zacks Investment Research

McKesson (MCK) to Report Q3 Earnings: Is a Beat in the Cards?

McKesson's (MCK) fiscal third-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

1 week ago - Zacks Investment Research

McKesson Corporation Declares Quarterly Dividend

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on...

1 week ago - Business Wire

McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

9 Best Stocks for Rising Interest Rates

The Federal Reserve has been aggressive in its rate hiking, and it's likely not done yet. Here are nine of the best stocks for rising interest rates.

2 weeks ago - Kiplinger

McKesson Receives Approval of Its Near-term Climate Change Targets by the Globally Recognized Science Based Targets initiative

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term climate change targets th...

2 weeks ago - Business Wire

4 Stocks Trading Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks like HRI, DCP, MRC and MCK that are seeing price strength have a high chance of carrying the momentum forward.

Other symbols: DCPHRIMRC
1 month ago - Zacks Investment Research

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Here is how McKesson (MCK) and Doctor Reddy's (RDY) have performed compared to their sector so far this year.

1 month ago - Zacks Investment Research

Jim Cramer predicts these ten S&P 500 stocks will perform well in 2023

Cramer named 10 stocks listed in the S&P 500 that he believes could perform well this year.

1 month ago - CNBC

These were Warren Buffett's 10 best performing stocks held by Berkshire Hathaway in 2022

Some of the best performers have been owned by Buffett for decades, like Coca-Cola, while others are new additions to the portfolio, like T-Mobile.

1 month ago - Business Insider

McKesson (MCK) Flat As Market Sinks: What You Should Know

In the latest trading session, McKesson (MCK) closed at $375.12, marking no change from the previous day.

1 month ago - Zacks Investment Research

Are Investors Undervaluing McKesson (MCK) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 month ago - Zacks Investment Research

3 Stocks to Sell Ahead of a Recession in 2023

If you are an investor looking for stocks to sell before a recession next year, you'll most likely be hitting the mark. While 2022 has been an alarming year for stocks due to rampant inflation and rat...

Other symbols: CVXUMH
1 month ago - InvestorPlace

McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023. The company will host...

1 month ago - Business Wire

Here's Why You Should Retain McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

1 month ago - Zacks Investment Research

McKesson (MCK) Announces Availability of FDA-Accepted Drug

The availability of FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PEComa.

1 month ago - Zacks Investment Research

McKesson (MCK) Announces Availability of FDA-Approved Drug

The availability of FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for AML.

1 month ago - Zacks Investment Research